YL242

· MediLink Therapeutics (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YL242, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of YL242 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]